623 related articles for article (PubMed ID: 14687985)
21. Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin.
Hsu CH; Hergenhahn M; Chuang SE; Yeh PY; Wu TC; Gao M; Cheng AL
Anticancer Res; 2002; 22(6C):4065-71. PubMed ID: 12553034
[TBL] [Abstract][Full Text] [Related]
22. Induction of inducible nitric oxide synthase by Epstein-Barr virus B95-8-derived LMP1 in Balb/3T3 cells promotes stress-induced cell death and impairs LMP1-mediated transformation.
Yu JS; Tsai HC; Wu CC; Weng LP; Li HP; Chung PJ; Chang YS
Oncogene; 2002 Nov; 21(52):8047-61. PubMed ID: 12439755
[TBL] [Abstract][Full Text] [Related]
23. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
24. [Effects of two LMP1 variants on resistance of CNE1 cell strain to TGF-beta1].
Huang H; Huang PC
Ai Zheng; 2003 Dec; 22(12):1254-9. PubMed ID: 14693046
[TBL] [Abstract][Full Text] [Related]
25. Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth.
Kim KR; Yoshizaki T; Miyamori H; Hasegawa K; Horikawa T; Furukawa M; Harada S; Seiki M; Sato H
Oncogene; 2000 Mar; 19(14):1764-71. PubMed ID: 10777210
[TBL] [Abstract][Full Text] [Related]
26. Antisense to Epstein Barr Virus-encoded LMP1 does not affect the transcription of viral and cellular proliferation-related genes, but induces phenotypic effects on EBV-transformed B lymphocytes.
Masciarelli S; Mattioli B; Galletti R; Samoggia P; Chichiarelli S; Mearini G; Mattia E
Oncogene; 2002 Jun; 21(26):4166-70. PubMed ID: 12037673
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.
Wen W; Iwakiri D; Yamamoto K; Maruo S; Kanda T; Takada K
J Virol; 2007 Jan; 81(2):1037-42. PubMed ID: 17079287
[TBL] [Abstract][Full Text] [Related]
28. Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1.
Kis LL; Takahara M; Nagy N; Klein G; Klein E
Immunol Lett; 2006 Apr; 104(1-2):83-8. PubMed ID: 16386314
[TBL] [Abstract][Full Text] [Related]
29. One-step multiplex real-time PCR assay to analyse the latency patterns of Epstein-Barr virus infection.
Kubota N; Wada K; Ito Y; Shimoyama Y; Nakamura S; Nishiyama Y; Kimura H
J Virol Methods; 2008 Jan; 147(1):26-36. PubMed ID: 17870188
[TBL] [Abstract][Full Text] [Related]
30. [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?].
Beck Z; Illés A; Keresztes K; Bessenyei B; Szöllosi Z; Kis A; Oláh E
Orv Hetil; 2006 Aug; 147(33):1539-44. PubMed ID: 17037676
[TBL] [Abstract][Full Text] [Related]
31. [Anti-apoptotic function of the Epstein-Barr virus LMP1 and BHRF1 proteins].
Kawanishi M
Nihon Rinsho; 1996 Jul; 54(7):1848-54. PubMed ID: 8741677
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells.
Niedobitek G; Agathanggelou A; Herbst H; Whitehead L; Wright DH; Young LS
J Pathol; 1997 Jun; 182(2):151-9. PubMed ID: 9274524
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus replicative gene transcription during de novo infection of human thymocytes: simultaneous early expression of BZLF-1 and its repressor RAZ.
Kelleher CA; Paterson RK; Dreyfus DH; Streib JE; Xu JW; Takase K; Jones JF; Gelfand EW
Virology; 1995 Apr; 208(2):685-95. PubMed ID: 7747440
[TBL] [Abstract][Full Text] [Related]
34. Restoration of the Epstein-Barr virus ZEBRA protein's capacity to disrupt latency by the addition of heterologous activation regions.
Baumann R; Warren G; Askovic S
Virology; 1995 Aug; 211(1):64-72. PubMed ID: 7645237
[TBL] [Abstract][Full Text] [Related]
35. Transcriptional activation of NF-kappa B activity by Epstein-Barr virus (EBV) LMP1 as a selective therapeutic strategy for EBV-associated diseases.
Wu CJ; Leu CY; Liu ST; Chow KP; Meng CL; Chang YS
Gene Ther; 1998 Jul; 5(7):905-12. PubMed ID: 9813661
[TBL] [Abstract][Full Text] [Related]
36. Regulation of matrix metalloproteinase-1 by Epstein-Barr virus proteins.
Lu J; Chua HH; Chen SY; Chen JY; Tsai CH
Cancer Res; 2003 Jan; 63(1):256-62. PubMed ID: 12517806
[TBL] [Abstract][Full Text] [Related]
37. Autocrine lymphotoxin production in Epstein-Barr virus-immortalized B cells: induction via NF-kappaB activation mediated by EBV-derived latent membrane protein 1.
Thompson MP; Aggarwal BB; Shishodia S; Estrov Z; Kurzrock R
Leukemia; 2003 Nov; 17(11):2196-201. PubMed ID: 14523478
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells.
Li HM; Zhuang ZH; Wang Q; Pang JC; Wang XH; Wong HL; Feng HC; Jin DY; Ling MT; Wong YC; Eliopoulos AG; Young LS; Huang DP; Tsao SW
Oncogene; 2004 May; 23(25):4488-94. PubMed ID: 15064751
[TBL] [Abstract][Full Text] [Related]
39. Lack of cytotoxic property in a variant of Epstein-Barr virus latent membrane protein-1 isolated from nasopharyngeal carcinoma.
Nitta T; Chiba A; Yamamoto N; Yamaoka S
Cell Signal; 2004 Sep; 16(9):1071-81. PubMed ID: 15212767
[TBL] [Abstract][Full Text] [Related]
40. Effect of a 10-amino acid deletion on the oncogenic activity of latent membrane protein 1 of Epstein-Barr virus.
Li SN; Chang YS; Liu ST
Oncogene; 1996 May; 12(10):2129-35. PubMed ID: 8668338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
